Chie Hatori

844 total citations
19 papers, 747 citations indexed

About

Chie Hatori is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Chie Hatori has authored 19 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 12 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Chie Hatori's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (16 papers), Peptidase Inhibition and Analysis (9 papers) and Phytochemical compounds biological activities (7 papers). Chie Hatori is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (16 papers), Peptidase Inhibition and Analysis (9 papers) and Phytochemical compounds biological activities (7 papers). Chie Hatori collaborates with scholars based in Japan and Norway. Chie Hatori's co-authors include Noriaki Inamura, Masayuki Asano, Hiroshi Kayakiri, Yoshito Abe, Teruo Oku, Yuki Sawada, Shigeki Satoh, Hirokazu Tanaka, Hiroe Sawai and Ichiro Aramori and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Chie Hatori

19 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chie Hatori Japan 14 321 300 279 96 79 19 747
Hiroe Sawai Japan 9 262 0.8× 106 0.4× 162 0.6× 69 0.7× 64 0.8× 11 413
Peter R. Seoane United States 11 238 0.7× 168 0.6× 175 0.6× 68 0.7× 62 0.8× 17 491
Danny Tam United States 14 84 0.3× 119 0.4× 449 1.6× 144 1.5× 58 0.7× 25 870
Brent Douty United States 9 154 0.5× 98 0.3× 379 1.4× 101 1.1× 33 0.4× 14 607
Mary Adams United States 14 175 0.5× 382 1.3× 329 1.2× 349 3.6× 180 2.3× 26 1.1k
Meredith Williams Singapore 15 94 0.3× 400 1.3× 356 1.3× 124 1.3× 57 0.7× 23 887
John S. Zuzack United States 13 260 0.8× 53 0.2× 223 0.8× 94 1.0× 75 0.9× 20 404
Pierre Dodey France 10 124 0.4× 131 0.4× 297 1.1× 42 0.4× 41 0.5× 22 469
Joy Bauch United States 12 53 0.2× 172 0.6× 456 1.6× 182 1.9× 29 0.4× 20 751
Rémy Morgentin France 13 33 0.1× 301 1.0× 292 1.0× 173 1.8× 52 0.7× 23 624

Countries citing papers authored by Chie Hatori

Since Specialization
Citations

This map shows the geographic impact of Chie Hatori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chie Hatori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chie Hatori more than expected).

Fields of papers citing papers by Chie Hatori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chie Hatori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chie Hatori. The network helps show where Chie Hatori may publish in the future.

Co-authorship network of co-authors of Chie Hatori

This figure shows the co-authorship network connecting the top 25 collaborators of Chie Hatori. A scholar is included among the top collaborators of Chie Hatori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chie Hatori. Chie Hatori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Takeshita, Nobuaki, et al.. (2011). Alleviating Effects of AS1892802, a Rho Kinase Inhibitor, on Osteoarthritic Disorders in Rodents. Journal of Pharmacological Sciences. 115(4). 481–489. 20 indexed citations
2.
Hatori, Chie, et al.. (2010). Antinociceptive Effects of AS1892802, a Novel Rho Kinase Inhibitor, in Rat Models of Inflammatory and Noninflammatory Arthritis. Journal of Pharmacology and Experimental Therapeutics. 334(3). 955–963. 31 indexed citations
3.
Sawada, Yuki, Hiroshi Kayakiri, Yoshito Abe, et al.. (2004). A New Series of Highly Potent Non-Peptide Bradykinin B2 Receptor Antagonists Incorporating the 4-Heteroarylquinoline Framework. Improvement of Aqueous Solubility and New Insights into Species Difference. Journal of Medicinal Chemistry. 47(7). 1617–1630. 46 indexed citations
4.
Sawada, Yuki, Hiroshi Kayakiri, Yoshito Abe, et al.. (2004). Discovery of the First Non-Peptide Full Agonists for the Human Bradykinin B2Receptor Incorporating 4-(2-Picolyloxy)quinoline and 1-(2-Picolyl)benzimidazole Frameworks. Journal of Medicinal Chemistry. 47(11). 2853–2863. 106 indexed citations
5.
Sawada, Yuki, Hiroshi Kayakiri, Yoshito Abe, et al.. (2004). A New Class of Nonpeptide Bradykinin B2Receptor Ligand, Incorporating a 4-Aminoquinoline Framework. Identification of a Key Pharmacophore To Determine Species Difference and Agonist/Antagonist Profile. Journal of Medicinal Chemistry. 47(10). 2667–2677. 13 indexed citations
6.
Hatori, Chie, et al.. (2002). Novel potent antagonists of human neuropeptide Y-Y5 receptor. Part 4: tetrahydrodiazabenzazulene derivatives. Bioorganic & Medicinal Chemistry Letters. 12(7). 1009–1011. 13 indexed citations
7.
Asano, Masayuki, Noriaki Inamura, Chie Hatori, et al.. (1999). Discovery of orally active nonpeptide bradykinin B2 receptor antagonists. Immunopharmacology. 43(2-3). 163–168. 11 indexed citations
8.
Aramori, Ichiro, Junko Zenkoh, Noriyuki Morikawa, et al.. (1999). Nonpeptide mimic of bradykinin with long-acting properties. Immunopharmacology. 45(1-3). 185–190. 6 indexed citations
9.
Asano, Masayuki, Chie Hatori, Hiroe Sawai, et al.. (1998). Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997. British Journal of Pharmacology. 124(3). 441–446. 30 indexed citations
10.
Abe, Yoshito, Hiroshi Kayakiri, Shigeki Satoh, et al.. (1998). A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 4. Discovery of Novel Frameworks Mimicking the Active Conformation. Journal of Medicinal Chemistry. 41(23). 4587–4598. 58 indexed citations
11.
Abe, Yoshito, Hiroshi Kayakiri, Shigeki Satoh, et al.. (1998). A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 3. Discovering Bioisosteres of the Imidazo[1,2-a]pyridine Moiety. Journal of Medicinal Chemistry. 41(21). 4062–4079. 69 indexed citations
12.
Abe, Yoshito, Hiroshi Kayakiri, Shigeki Satoh, et al.. (1998). A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 2. Overcoming the Species Difference between Guinea Pig and Man. Journal of Medicinal Chemistry. 41(21). 4053–4061. 35 indexed citations
13.
Abe, Yoshito, Hiroshi Kayakiri, Shigeki Satoh, et al.. (1998). A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 1. Construction of the Basic Framework. Journal of Medicinal Chemistry. 41(4). 564–578. 83 indexed citations
14.
Aramori, Ichiro, Junko Zenkoh, Noriyuki Morikawa, et al.. (1998). Nonpeptide Mimic of Bradykinin with Long-Acting Properties at the Bradykinin B2 receptor. The Japanese Journal of Pharmacology. 76. 113–113. 2 indexed citations
15.
Asano, Masayuki, Chie Hatori, Noriaki Inamura, et al.. (1997). Effects of a nonpeptide bradykinin B2 receptor antagonist, FR167344, on different in vivo animal models of inflammation. British Journal of Pharmacology. 122(7). 1436–1440. 36 indexed citations
16.
Asano, Masayuki, Noriaki Inamura, Chie Hatori, et al.. (1997). The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657. British Journal of Pharmacology. 120(4). 617–624. 92 indexed citations
17.
Inamura, Noriaki, Masayuki Asano, Chie Hatori, et al.. (1997). Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B2 receptor antagonist, FR167344. European Journal of Pharmacology. 333(1). 79–86. 18 indexed citations
18.
Aramori, Ichiro, Junko Zenkoh, Noriyuki Morikawa, et al.. (1997). Nonpeptide Mimic of Bradykinin with Long-Acting Properties at the Bradykinin B2 Receptor. Molecular Pharmacology. 52(1). 16–20. 56 indexed citations
19.
Inamura, Noriaki, et al.. (1997). Characterization of FR173657, a novel nonpeptide B2antagonist: in vitro and in vivo studies. Canadian Journal of Physiology and Pharmacology. 75(6). 622–628. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroe Sawai Breakdown of academic impact, for papers by Peter R. Seoane Breakdown of academic impact, for papers by Danny Tam Breakdown of academic impact, for papers by Brent Douty Breakdown of academic impact, for papers by Mary Adams Breakdown of academic impact, for papers by Meredith Williams Breakdown of academic impact, for papers by John S. Zuzack Breakdown of academic impact, for papers by Pierre Dodey Breakdown of academic impact, for papers by Joy Bauch Breakdown of academic impact, for papers by Rémy Morgentin
Rankless by CCL
2026